目的 探讨中国妇女孕期增重与出生结局的关联。方法 收集孕妇孕前BMI、产前体重及出生结局信息,计算孕期总增重,分别根据我国卫生标准WS/T 801-2022与美国IOM 2009指南判定增重不足、适宜或过多;评估的不良出生结局包括:小体型脆弱新生儿(SVN:小于胎龄儿、早产、或低出生体重之和)和大体型儿(大于胎龄儿或巨大儿);Logistic回归分析孕期增重与不良出生结局的关联,估计比值比(OR)及95%置信区间(CI)。结果 共8126对母婴纳入本研究。按WS/T801标准,孕期增重不足、适宜、过多的占比分别为7.6%、42.3%、50.1%;按IOM 2009标准,孕期增重不足、适宜、过多的占比分别为23.7%、42.1%、34.2%;12.7%的婴儿为SVN,12.8%为大体型儿,合计24.5%为不良出生结局。基于WS/T801,与孕前BMI正常且增重适宜组相比,孕前消瘦及BMI正常人群中,增重不足组发生SVN的OR(95%CI)分别为2.00(1.38,2.90)和1.77(1.32,2.36);增重过多组大体型儿的分别为1.66(1.18,2.34)、2.21(1.84,2.65),孕前超重/肥胖组孕期增重过多者大体型儿的OR(95%CI)为3.38(2.73,4.18);孕前BMI正常和孕前超重/肥胖组,增重过多者发生不良出生结局的OR(95%CI)分别为1.15(1.01,1.32)和1.53(1.29,1.82),孕前消瘦和BMI正常组,增重不足者不良出生结局的OR(95%CI)为1.33 (1.01, 1.74)和1.47(1.03,2.10)。基于IOM标准,孕前超重或肥胖且孕期增重适宜组发生不良出生结局的OR(95%CI)为1.38(1.10,1.72)。结论 WS/T 801及IOM标准均可降低不良出生结局的发生风险,WS/T 801标准更有利于指导中国妇女预防SVN和大体型儿,从而获得良好出生结局。
Abstract
Objective To explore the association between gestational weight gain (GWG) and birth outcomes among Chinese women. Methods We collected data on pre-pregnancy BMI, prenatal weight, and birth outcomes. Total GWG was calculated and categorized as insufficient, appropriate, or excessive based on the Chinese health standard (WS/T 801-2022) and the IOM 2009 guidelines. Adverse birth outcomes included small vulnerable newborns (SVN: small for gestational age, low birth weight, or preterm birth), large-sized newborns (large for gestational age or macrosomia). Logistic regression analyses were performed to examine the associations between GWG and adverse birth outcomes, with odds ratios (ORs) and 95% confidence intervals (CIs) estimated. Results A total of 8,126 mother-infant pairs were included in the study. According to the WS/T 801, 7.6%, 42.3%, and 50.1% of the women had insufficient, appropriate, or excessive GWG, respectively, while under the IOM 2009, these proportions were 23.7%, 42.1%, and 34.2%, respectively. Among infants, 12.7% were SVN, 12.8% were large-sized newborns, and 24.5% presented with adverse birth outcomes. Based on the WS/T801, compared with the normal pre-pregnancy BMI and appropriate weight gain group, the OR (95% CI) for SVN in the pre-pregnancy underweight and normal BMI groups with insufficient weight gain were 2.00 (1.38, 2.90) and 1.77 (1.32, 2.36), respectively. For large-sized newborns, the OR (95% CI) in the excessive weight gain group were 1.66 (1.18, 2.34) and 2.21 (1.84, 2.65), respectively. In the pre-pregnancy overweight/obese group, the OR (95% CI) for large-sized newborns among those with excessive weight gain during pregnancy was 3.38 (2.73, 4.18). Among the normal pre-pregnancy BMI group and the pre-pregnancy overweight/obese group, the OR (95% CI) for adverse birth outcomes in those with excessive weight gain were 1.15 (1.01, 1.32) and 1.53 (1.29, 1.82), respectively. In the pre-pregnancy underweight and normal BMI groups, the OR (95% CI) for adverse birth outcomes in those with insufficient weight gain were 1.33 (1.01, 1.74) and 1.47 (1.03, 2.10), respectively. Based on the IOM criteria, the OR (95% CI) for adverse birth outcomes in the pre-pregnancy overweight or obese group with appropriate weight gain was 1.38 (1.10, 1.72). Conclusion Both the WS/T 801 and IOM 2009 criteria can reduce the risk of adverse birth outcomes. The WS/T 801 standard is more conducive to guiding Chinese women in preventing SVN and large-sized newborns, and thereby achieving favorable birth outcomes.
关键词
孕期增重 /
出生结局 /
增重标准
Key words
gestational weight gain /
birth outcome /
weight gain criteria
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Chuang YC, Huang L, Lee WY, et al. The association between weight gain at different stages of pregnancy and risk of gestational diabetes mellitus[J]. J Diabetes Investig, 2022,13:359–366.
[2] Salavati N, Bakker MK, Lewis F, et al. Associations between preconception macronutrient intake and birth weight across strata of maternal BMI[J]. PLoS One, 2020, 15: e243200.
[3] Institute of Medicine (US) andNational Research Council Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight gain during pregnancy: reexamining the guidelines[M]. Washington (DC): National Academies Press (US); 2009.
[4] 中华人民共和国国家健康委员会WS/T 801—2022. 妊娠期妇女体重增长推荐值标准华人民共和国国家健康委员会WS/T 801—2022. 妊娠期妇女体重增长推荐值标准[S]. 北京:中华人民共和国国家卫生健康委员会, 2022.
[5] Lyu Y, Cui M, Zhang L, et al. Pre-pregnancy body mass index, gestational diabetes mellitus, and gestational weight gain: individual and combined effects on fetal growth[J]. Front Public Health, 2024,12:1354355.
[6] Lin L, Lin J.Interactive effects and relative contribution of prepregnancy overweight and obesity, excessive gestational weight gain and gestational diabetes mellitus to macrosomia: a retrospective cohort in Fujian, China[J]. Eur J Obstet Gynecol Reprod Biol, 2024,296:354–359.
[7] Sun C, Wu Y, Cai Z, et al. Maternal dietary diversity and small for gestational age: the effect modification by pre-pregnancy body mass index and gestational weight gain in a prospective study within rural Sichuan, China (2021-2022)[J]. Nutrients, 2023,15:3669.
[8] Lawn JE, Ohuma EO, Bradley E, et al. Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting[J]. Lancet, 2023,401:1707–1719.
[9] Yang X, Wang G, Liu N, et al. Mediating effect of gestational weight gain on the preventive effect of exercise during pregnancy on macrosomia: a randomized clinical trial[J]. BMC Pregnancy Childbirth, 2024,24:384.
[10] 中华医学会妇产科学分会产科学组, 围产医学分会妊娠合并糖尿病协作组. 妊娠合并糖尿病诊治指南(2014)[J]. 糖尿病临床, 2014,8:489-498.
[11] 中国肥胖问题工作组. 中国成人超重和肥胖症预防与控制指南(节录)[J]. 营养学报, 2004,26:1–4.
[12] 宗心南, 李辉, 张亚钦, 等. 中国不同出生胎龄新生儿体重身长比、体质指数和重量指数的参照标准及生长曲线[J]. 中华儿科杂志, 2021,59:181–188.
[13] Peng Z, Si S, Cheng H, et al. The associations of maternal hemoglobin concentration in different time points and its changes during pregnancy with birth weight outcomes[J]. Nutrients, 2022,14:2542.
[14] 张莉, 郑薇, 王佳, 等. 中国卫生行业标准与美国医学研究所指南评价我国单胎孕妇妊娠期体质量增长与妊娠结局的比较研究[J]. 中国全科医学, 2023,26:2959–2967.
[15] 王杰, 段一凡, 庞学红, 等. 2013年中国足月单胎产妇孕期增重情况及适宜范围探讨[J]. 中华预防医学杂志; 2018,52:31–37.
[16] Ashorn P, Ashorn U, Muthiani Y, et al. Small vulnerable newborns-big potential for impact[J]. Lancet, 2023,401:1692–1706.
[17] Wang S, Villagran E G, Chen Z, et al. Association of vitamin D intake during pregnancy with small vulnerable newborns: a population-based cohort study[J]. Food Funct, 2024,15:7896–7906.
[18] Hunter PJ, Awoyemi T, Ayede AI, et al. Biological and pathological mechanisms leading to the birth of a small vulnerable newborn[J]. Lancet, 2023,401:1720–1732.
[19] Yang S, Peng A, Wei S, et al. Pre-pregnancy body mass index, gestational weight gain, and birth weight: a cohort study in China[J]. PLoS One, 2015,10: e130101.
[20] Zhao R, Xu L, Wu ML, et al. Maternal pre-pregnancy body mass index, gestational weight gain influence birth weight[J]. Women Birth, 2018,31: e20–e25.
基金
科技基础资源调查专项《孕产妇营养与健康体格检查数据采集》(No.2019FY101003)